Last update:

Ophthalmology news

New strategies help slow myopia progression in children and teens

By 2050, an estimated 50% of the world's population will be nearsighted, and nearly a billion people will suffer from severe myopia. To understand this alarming trend, Langis Michaud is doing a thorough review of medical ...

New approach offers hope for people with rare eye cancer

Researchers at Queen Mary's Barts Cancer Institute have found a more active approach to monitoring and treating people with a rare eye cancer (known as uveal melanoma) that has spread to the liver could help some patients ...

Clinical trial in Ethiopia targets the trachoma scourge

Trachoma is the leading cause of infectious blindness in the world, with Ethiopia the most impacted country in Africa. In a clinical trial of more than 2,400 individuals, researchers led by Dr. John Kempen of Mass Eye and ...

Genetic study uncovers unknown causes of blindness

Researchers from Radboud University Medical Center and University of Basel have discovered new genetic causes of inherited blindness. Their study, published in Nature Genetics, shows that changes in specific pieces of DNA, ...

Genes aren't destiny for inherited blindness, study shows

A new study challenges what's long been assumed about genetic variants thought to always cause inherited blindness. Investigators from Mass General Brigham used large public biobanks to determine that genes thought to cause ...

Eye scan can reveal risk of having a heart attack or stroke

A simple digital photograph of the back of the eye can predict a major cardiovascular event—such as a heart attack or stroke—set to happen in the next decade with 70% accuracy, according to research supported by the British ...

Cancer drug shows promise as treatment for blindness

Singapore researchers have discovered that a new cancer drug, originally developed at A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB), shows potential as a new treatment approach for two leading causes of blindness ...

NRTI use linked to risk for primary open-angle glaucoma

Use of nucleoside and nucleotide reverse transcriptase inhibitors (NRTIs) is associated with an increased risk for primary open-angle glaucoma (POAG), according to a study published online June 20 in Ophthalmology.